• 2023
  De Thoisy A, Woudenberg T, Pelleau S, Donnadieu F, Garcia L, Pinaud L, Tondeur L, Meola A, Arowas L, Clement N, Backovic M, Ungeheuer MN, Fontanet A, White M, Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France., Open Forum Infect Dis 2023 Jul; 10(7): ofad340.
• 2023
  Woudenberg T, Pinaud L, Garcia L, Tondeur L, Pelleau S, De Thoisy A, Donnadieu F, Backovic M, Attia M, Hozé N, Duru C, Koffi AD, Castelain S, Ungeheuer MN, Fernandes Pellerin S, Planas D, Bruel T, Cauchemez S, Schwartz O, Fontanet A, White M, Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 Nov; 224(9): 1489-1499.
• 2018
  Pinaud L, Sansonetti PJ, Phalipon A, Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors., Trends Microbiol 2018 Apr; 26(4): 266-283.
• 2018
  Belotserkovsky I, Brunner K, Pinaud L, Rouvinski A, Dellarole M, Baron B, Dubey G, Samassa F, Parsot C, Sansonetti P, Phalipon A, Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes., mBio 2018 Feb; 9(1): .
• 2017
  Pinaud L, Samassa F, Porat Z, Ferrari ML, Belotserkovsky I, Parsot C, Sansonetti PJ, Campbell-Valois FX, Phalipon A, Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes., Proc Natl Acad Sci U S A 2017 Sep; 114(37): 9954-9959.
• 2017
  Pinaud L, Ferrari ML, Friedman R, Jehmlich N, von Bergen M, Phalipon A, Sansonetti PJ, Campbell-Valois FX, Identification of novel substrates of Shigella T3SA through analysis of its virulence plasmid-encoded secretome., PLoS One 2017 ; 12(10): e0186920.
• 2014
  Nothelfer K, Arena ET, Pinaud L, Neunlist M, Mozeleski B, Belotserkovsky I, Parsot C, Dinadayala P, Burger-Kentischer A, Raqib R, Sansonetti PJ, Phalipon A, B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection., J Exp Med 2014 Jun; 211(6): 1215-29.
• 2012
  McGourty K, Thurston TL, Matthews SA, Pinaud L, Mota LJ, Holden DW, Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function., Science 2012 Nov; 338(6109): 963-7.
• 2012
  White RE, Rämer PC, Naresh KN, Meixlsperger S, Pinaud L, Rooney C, Savoldo B, Coutinho R, Bödör C, Gribben J, Ibrahim HA, Bower M, Nourse JP, Gandhi MK, Middeldorp J, Cader FZ, Murray P, Münz C, Allday MJ, EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors., J Clin Invest 2012 Apr; 122(4): 1487-502.
• 1975
  Boegman RJ, Wood PL, Pinaud L, Increased axoplasmic flow associated with pargyline under conditions which induce a myopathy., Nature 1975 Jan; 253(5486): 51-2.